2026 Amyloidosis Forum Annual Meeting
30 września
The 2026 Amyloidosis Forum Annual Meeting will bring together clinicians, researchers, FDA and global health authorities, industry partners, patients and the Amyloidosis Research Consortium. Participants will present the work of stakeholder groups focused on accelerating drug development in AL and ATTR amyloidosis.
Detailed information are available on the event website.